TrialRheumatology (Oxford, England)2024

Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study.

Roberto Caporali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.